As of 2025-08-04, the Intrinsic Value of Episil-Precision Inc (3016.TW) is 28.32 TWD. This 3016.TW valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 33.15 TWD, the upside of Episil-Precision Inc is -14.60%.
The range of the Intrinsic Value is 21.85 - 42.61 TWD
Based on its market price of 33.15 TWD and our intrinsic valuation, Episil-Precision Inc (3016.TW) is overvalued by 14.60%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 21.85 - 42.61 | 28.32 | -14.6% |
DCF (Growth 10y) | 34.00 - 67.73 | 44.58 | 34.5% |
DCF (EBITDA 5y) | 51.67 - 71.21 | 60.01 | 81.0% |
DCF (EBITDA 10y) | 60.89 - 90.00 | 73.16 | 120.7% |
Fair Value | 19.65 - 19.65 | 19.65 | -40.72% |
P/E | 26.54 - 37.88 | 31.48 | -5.0% |
EV/EBITDA | 29.79 - 53.46 | 36.46 | 10.0% |
EPV | 13.33 - 16.08 | 14.71 | -55.6% |
DDM - Stable | 6.03 - 16.14 | 11.09 | -66.6% |
DDM - Multi | 23.19 - 49.19 | 31.63 | -4.6% |
Market Cap (mil) | 9,565.10 |
Beta | 1.35 |
Outstanding shares (mil) | 288.54 |
Enterprise Value (mil) | 8,382.56 |
Market risk premium | 5.98% |
Cost of Equity | 10.25% |
Cost of Debt | 4.25% |
WACC | 9.38% |